A new treatment for some cancers includes the use of conjugated monoclonal antibodies, which have an anti-cancer drug attached - VCE - SSCE Biology - Question 19 - 2021 - Paper 1

The primary advantage of using conjugated monoclonal antibodies is their ability to selectively target cancerous cells while minimizing collateral damage to non-cancerous cells. By reducing the impact of the anti-cancer drug on healthy cells, these antibodies help to mitigate potential side effects and enhance the overall effectiveness of treatment. This targeted approach is crucial for improving patient outcomes in cancer therapy.